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a  b  s  t  r  a  c  t
An  NC-1  mimotope  from  Taenia  solium  cysticerci  can  help  identify  patients  with  neurocysticercosis
through immunoassay.  After  chemical  synthesis,  an  NC-1  peptide  was  coupled  to  bovine  serum  albumin
(NC-1/BSA)  for  used  as  an  immunogen  in murine  Taenia  crassiceps  cysticercosis,  which  is an experimental
model  of  cysticercosis  caused  by T. solium.  NC-1/BSA  immunisation  decreased  parasitaemia  by inducing
74%  protection  compared  to the  77%  protection  obtained  with  T. crassiceps  crude  antigen.  The  inﬂuence
of  immunisation  was  also  observed  on  the  size  and stage  of  development  of  the  parasite.  Antibodies  fromeywords:
imotope
ynthetic peptide
mmunoprotection
aenia  solium
aenia  crassiceps
NC-1/BSA-immunised  mice  recognised  proteins  from  the  tegument  and  from  the  buddings,  and  intense
immunostaining  was  observed  in  the  ﬁnal  stage  of the  metacestode.  The  capacity  of NC-1/BSA  to  induce
protective  antibodies  which  are  reactive  to  proteins  from  the  tegument  of the metacestode  suggests  that
this  mimotope  is  a  potential  candidate  for a  vaccine  against  human  and  animal  cysticercosis.
© 2011 Elsevier Ltd. Open access under the Elsevier OA license.
ysticercosis
. Introduction
The metacestode stage (larvae) of Taenia solium, also known
s Cysticercus cellulosae, is responsible for muscular and cerebral
ysticercosis (neurocysticercosis [NCC]) in humans. The life cycle
f T. solium includes pigs as intermediate hosts. Humans are the
nly known deﬁnitive host of the adult form, but they can act as
ccidental hosts through faecal-oral contamination with tapeworm
ggs (hetero- or self-infection). Eggs hatch in the intestines, and
he hexacant embryos penetrate the intestinal mucosa, dissemi-
ate through the bloodstream, and lodge in muscle, soft tissue, and
he central nervous system [1].
To develop new alternatives for serological NCC diagnosis, in
009, our group used phage display biotechnology to ﬁnd an amino
∗ Corresponding author at: Departamento de Patologia Básica, UFPR, Setor de
iências  Biológicas, CP 19040 Jardim das Américas, CEP 81531-990 Curitiba, Paraná,
razil. Tel.: +55 41 3361 1692; fax: +55 41 3266 2042.
E-mail addresses: julianademoura@ufpr.br,  julianademoura@yahoo.com.br
J.  de Moura).
264-410X ©  2011 Elsevier Ltd. 
oi:10.1016/j.vaccine.2011.10.027
Open access under the Elsevier OA license.acid sequence capable of identifying patients with NCC through
indirect enzyme-linked immunosorbent assay (ELISA). We  have
demonstrated that, after chemical synthesis, the peptide NC-1
(SKSSITITNKRLTRK), a mimotope of T. solium, induced a humoral
response in mice, in which antibodies recognised proteins from the
scolex region during immunohistochemical study [2].
Considering previous studies about the capacity of phage-
displayed peptides to induce protection against toxins [3], bacteria
[4], viruses [5], fungi [6], and parasites [7,8], we sought to explore
the potential of a synthetic peptide (NC-1), screened by antibodies
against T. solium metacestode, to induce an immune response that
could protect mice against murine cysticercosis. To provide more
realistic tests for a vaccine candidate, a permissive host and a non-
syngeneic (outbred) strain, as the genetically heterogeneous Swiss
mice, was  immunised with NC-1 coupled to BSA (NC-1/BSA) and
challenged with cysticerci from T. crassiceps, and the capacity to
induce protection was assessed as the reduction in worm burden
[9].
Experiments with this Taeniidae are possible because its
metacestode reproduces asexually by budding through intraperi-
toneal passage of mice [10], and it is usually used in immunological
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nd biochemical studies of cysticercosis [11–13] or as source of
eterologous antigen in NCC immunoassays [14–16]. Therefore,
urine cysticercosis was chosen as a model in our investigation
ecause of the ease of maintaining T. crassiceps metacestode in
he laboratory and measuring parasite loads without biohazard
isks and because T. crassiceps and T. solium are phylogenetically
elated.
The results of our immunohistochemical studies revealed that
he recognition proﬁle of T. crassiceps cysticercus by antibodies
roduced against NC-1/BSA corroborates the fact that T. crassiceps
hares antigens with T. solium [13,16]. Furthermore, the protective
otential of the NC-1 synthetic mimotope coupled to BSA indi-
ated that synthetic mimotopes selected by phage display could
e important vaccine candidates against parasites.
. Material and methods
.1.  Animals
Seven to 8-week-old female Swiss mice were maintained at the
iotery of Centro de Pesquisa e Produc¸ ão de Imunobiológicos (CPPI),
iraquara – PR, in accordance with guidelines of the local animal
thics committee. The animals were divided into 3 groups, each
ontaining 8 or 9 mice. Both groups were given ad libitum access to
ood and water.
.2.  Antigen preparation
NC-1  was chemically synthesized including a terminal cys-
eine residue and coupled to bovine serum albumin (BSA) as
escribed by Hell et al. [2]. BSA diluted in 20 mM sodium phosphate
uffer (pH 7.4) containing 0.15 M sodium chloride was activated
hrough reaction with sulfosuccinimidyl 4-(N-maleimidomethyl)
yclohexane-1-carboxylate (Pierce Chemical Co., Rockford, IL), in
oncentration of 10 mg/mL. The solution was maintained at room
emperature for 1 h under stirring. The excess reagent was removed
ith elution through a disposable PD-10 column. The activated
SA was reacted with the cysteine-containing peptide (5 mg/mL) at
oom temperature for 2 h under stirring and protected from light.
o stop the conjugation reaction, buffer containing 1 mM reduced
ysteine was added. The peptide coupled to BSA was aliquoted and
tored at −20 ◦C.
Crude antigen from an open reading frame (ORF) strain of T. cras-
iceps (TcCa) was maintained by consecutive passage of cysticerci
n the peritoneal cavities of mice and processed as described by Vaz
t al. [14].
.3.  In silico analysis of the NC-1 sequence
The NC-1 amino acid sequence corresponding to SKSSI-
ITNKRLTRK [2] was analysed for sequence similarity to
ther sequences from Taeniidae specimens using the Basic
ocal Alignment Search Tool (BLAST) algorithm [17] on the
ational Center for Biotechnology Information public database
http://blast.ncbi.nlm.nih.gov/Blast.cgi). In June 2011, each search
as limited to just a single organism whose alignment had an
-value lower than 1.0. The following Taeniidae non-redundant
nr) sequence databases were accessed: T. crassiceps, T. solium,
aenia saginata, Taenia hydatigena, Taenia multiceps, Taenia pisi-
ormis and Taenia taeniaeformis. The theoretical isoelectric point
pI) and molecular weight (Mw) of Taenia sp proteins were
btained from the Compute pI/Mw Program [18] at Expasy
http://expasy.org/tools/pi tool.html).e 29 (2011) 9473– 9479
2.4.  Immunogen preparation and immunisation
In the ﬁrst immunisation, mice were injected subcutaneously
into the intra-scapular fold with one dose, i.e. 20 g of NC-1 pep-
tide coupled to BSA (NC-1/BSA), TcCa, or BSA dissolved in 50 mM
phosphate buffered saline, pH 7.4 (PBS) and emulsiﬁed with com-
plete Freund’s adjuvant (1:1, volume ratio) in a total volume of
100 L. Following the guidelines of the animal ethics committee,
the boost immunisation using the same route was avoided due to
lesions caused by the complete Freund’s adjuvant, and at 2-week
intervals, animals received new intra-peritoneal doses of immuno-
gens emulsiﬁed with incomplete Freund’s adjuvant. One week after
the fourth and eighth immunisation, approximately 50 L of blood
was collected from the mice by retro-orbital bleeding to measure
antibody reactivity with ELISA.
2.5. ELISA evaluation of antibody reactivity
Plates with 96 wells (Falcon Labware, Oxnard, CA) were coated
during 16 h at 4 ◦C with 10 g/mL of the 3 antigens (non-coupled
NC-1 peptide, TcCa, and BSA) dissolved in 50 mM carbonate buffer
pH 9.6. After blocking with 2% (w/v) casein diluted in 50 mM phos-
phate buffered saline, pH 7.4 (PBS) and 0.05% (v/v) Tween 20,
the mouse sera against each antigen diluted 1:100 in incubation
buffer (Tween 20, 0.25% (w/v) casein) was  added to each well and
incubated at 37 ◦C for 1 h. The binding antibody was quantiﬁed
using goat anti-mouse IgG (whole molecule)-horseradish peroxi-
dase (Sigma # A4416) diluted 1:4000. The reaction was revealed
using orthophenylenediamine and H2O2 and stopped by adding
20 L of 2 N sulfuric acid. Absorbance readings (A492 nm) were car-
ried out in ELISA reader.
2.6.  T. crassiceps metacestode infection
Following the protocol described above, mice were given a
booster 1 week after the second blood sample was obtained. One
week later, animals were infected with an intra-peritoneal injec-
tion of 5 cysticerci of T. crassiceps resuspended in 100 L of PBS.
Four weeks after this challenge, the animals were euthanised, and
peritoneal washing in phosphate-buffered saline (150 mM NaCl,
10 mM sodium phosphate buffer and pH 7.2) was used to remove
the cysticerci, which were counted and classiﬁed according to their
stage of development (non-budding, larval, and ﬁnal stage). Percent
reduction of parasitaemia was calculated as follows: [1 − (mean
worm burden of vaccinated group/mean worn burden of BSA
group)] × 100.
2.7. Immunohistochemistry
T.  crassiceps metacestodes in the 2–3 mm larval stage (char-
acterised by buddings) and in the ﬁnal stage of development (a
non-budding opaque vesicle) [11] were taken from an unrelated
infected mouse and ﬁxed in 4% (v/v) paraformaldehyde for 20 min.
After washing in PBS (2.7 mM KCl, 1.8 mM KH2PO4, 137 mM NaCl,
10 mM Na2HPO4, pH 7.2, 304 mOsm/kg H2O), the samples were
embedded in Tissue-Tek OCT (Sakura), frozen with liquid nitro-
gen, and stored at −80 ◦C. The tissues were sectioned 7 m thick
using a Leica CM1850 cryostat (Leica Microsystems, Germany) and
placed on slides prepared with a 2% solution of Biobond (EMS) in
acetone for 4 min. The slides were then rinsed for 5 min  in dis-
tilled water and air dried. Additionally, aldehyde radicals were
blocked with 100 mM glycine for 2 min  and washed with PBS. Non-
speciﬁc sites were blocked for 30 min  with 2% casein diluted in
PBS and 0.1% (v/v) Triton X-100, and sections were incubated for
2 h with pool of sera from immunised mice diluted 1:50 in PBS
containing 2% (w/v) casein. Unbound antibodies were removed
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Paramyosin  (T.  solium )*                 TKSALRDANRRLTDL 
DMAERTITIKRTIGG 
 82 9            834 
 43 2        436 
NC-1 peptide                   SKS SITITNKRLTR K 
Cytochrom e c oxidase subu nit III  (T. crass icep s)         ILLGSSITI TAFHHLLG 
Cytochrom e c oxidase subu nit III  (T. solium)*        VLLGSSITVTAFHHLLG 
 10 2             107  
NADH de hydrogenase  subunit 4  (T. crass icep s)*       VLIKSSINGINLIMIVV 
 316                   323  
Fig. 1. Pair wise alignment of the deduced amino acid sequence of NC-1 with Tae-
nia spp proteins. Bold letters denote the consensus sequences between the NC-1
peptide and the Taenia spp protein sequence from GenBank. The numbering below
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Fig. 2. Hyperimmune serum speciﬁcity (A) and reactivity (A and B) in mice immu-
nised  with bovine serum albumin (BSA; ), Taenia crassiceps crude antigen (TcCa;
), and NC-1 peptide coupled to bovine serum albumin (NC-1/BSA; ), against
non-coupled NC-1 peptide and BSA, and against each immunogen, respectively. The
antibody reactivity of the ﬁrst blood samples (A) was dissimilar (ANOVA, post hoc
For improving the normality of variables, data from recoveredhe alignment refers to the amino acid position in the protein sequence. *The same
lignment results were obtained with other Taenia spp.
ith 3 washes in PBS. Finally, Alexa 488 conjugated anti-mouse
econdary antibodies (Invitrogen) were diluted 1:250 in PBS con-
aining 2% (w/v) casein and incubated for 1 h protected from light
t room temperature. For nuclear staining, 10 M 4′,6-diamindino-
-phenylindole was applied for 5 min. Samples preparations were
xamined using a Zeiss Axio Observer Z1 inverted microscope (Carl
eiss, Germany). The ﬂuorescent probe was excited at 488 nm with
mission using the LP 505 nm ﬁlter (green channel). Single images
ere obtained with a monochromatic camera (AxioCam HRm, Carl
eiss, Germany) using a 40× lens for differential interface contrast
nd ﬂuorescence intensity. Finally, AxioVision LE software was  used
or image processing and for morphometric measurements in the
eiss image format.
.8.  Statistical analysis
One-way  analysis of variance (ANOVA) was used for statistical
nalysis of the results, and the Tukey test was used for pair wise
omparison of samples. The signiﬁcance of the difference in fre-
uency of initial-, larval-, or ﬁnal-stage cysticerci among groups
as determined with the Chi-square test. Mean parasite length
etween NC-1/BSA and TcCa immunised groups was  compared by
sing Student’s t test. A value of p < 0.05 was considered statistically
igniﬁcant.
. Results
.1. Similarities between NC-1 peptide sequence and Taenia sp
roteins
Using  bioinformatic analysis, we compared the NC-1 sequence
o primary sequences of Taenia sp proteins deposited in the
ational Institutes of Health GenBank database. The alignments
ndicated identity of NC-1 peptide to cytochrome c oxidase and
icotinamide adenine dinucleotide dehydrogenase (NADH), two
itochondrial proteins of the respiratory chain. Some matches
ith paramyosin, a component of invertebrate muscles, were also
bserved (Fig. 1).
Although  searches using short peptide sequences can be vir-
ually identical and have generally high E-value, our alignments
resented good E-values for cytochrome c oxidase subunit III that
anged from 0.004 (T. crassiceps) to 0.14 (T. solium). The NADH sub-
nit IV matches had E-value ranging from 0.25 (T. pisiformis) to 0.77Tukey test, p < 0.05). These results are represented by small letters (a, b, c). No sig-
niﬁcant difference was found between the second blood samples (B), which are
illustrated by bars with the same small letters (a, a, a).
(T. crassiceps). Table 1 lists the sequence similarities among NC-1
peptide and Taenia spp proteins.
3.2. Antibody reactivity after fourth and eighth immunisations
Serum samples were obtained after the fourth (ﬁrst bleeding)
and eighth immunisations (second bleeding), and were assayed
against the 3 antigens (BSA, TcCa, and non-coupled NC-1). ELISA
results revealed the presence of antibodies in all groups of mice;
however, the reactivity of serum from animals immunised with
TcCa were inferior compared to those of the other groups. Fur-
thermore, antibodies produced against NC-1/BSA were capable
of discriminating among the NC-1 peptide sequence and BSA
(Fig. 2A).
ANOVA indicated that the difference in reactivity among the 3
groups was  signiﬁcant (p < 0.05) with respect to the 3 immuno-
gens (BSA, TcCa, and NC-1/BSA). This result was interpreted as
if the dissimilarity among the immunogens was not the same
after the fourth and eighth immunisations. Thus, we comple-
mented our analysis with a comparison of the means using the
post hoc Tukey test. The inequality among the groups changed
after the booster. The Tukey test showed that after the eighth
immunisation, the mean antibody reactivity of the 3 mice groups
was equal (Fig. 2B). These results indicate that at the time of
challenge, the mice from 3 groups had the same immunisation
status.
3.3. Induction of protection by the NC-1 peptide
To analyse the protective potential of the NC-1 peptide, mice
were immunised with NC-1/BSA, TcCa (positive control), and BSA
(negative control). One week after the last booster, mice, including
the control group, were challenged with 5 small T. crassiceps cys-
ticerci. Thirty days later, the mice were euthanised, and the cysts
were counted. NC-1/BSA immunisation reduced the worm burden
by an average of 74.2% compared to the negative control (Table 2).
Similarly, in the group immunised with TcCa, protection reached
77.7%.cysticerci was  transformed by the equation
√
(x  + 0.5). Considering
the mean number of cysticerci from each group, it was  possible to
verify that animals immunised with the NC-1/BSA peptide or with
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Table 1
Alignment of NC-1 peptide with amino acid sequences from Taenia spp proteins.
Putative protein Theoretical pI/Mw  (kDa)a Taenia species (accession)b
Cytochrome c oxidase subunit I 6.0/60.5 T. taeniaeformis (YP 004062137)
Cytochrome c oxidase subunit III
4.8/24.9 T. crassiceps (NP 066229.2)
4.4/24.6 T. pisiformis (YP 003434404.1)
4.9/24.3 T. hydatigena (YP 003001995.1)
4.9/24.4 T. taeniaeformis (YP 004062129.1)
5.0/24.3 T. multiceps (YP 003001970.1)
5.3/24.4 T. solium (NP 659225.1)
NADH  dehydrogenase subunit IV
5.9/48.7 T. pisiformis (YP 003434407.1)
5.4/46.0 T. hydatigena (YP 003001998.1)
5.7/48.7 T. crassiceps (NP 066232.2)
Paramyosin  5.3/98.8
T. saginata (Q8T305.1)
T.  solium (AAT94289.1)
a Theoretical isoelectric point (pI) and molecular weight (Mw)  from proteins were calculated based on primary structure by using Expasy Compute pI/Mw tool
(www.http://expasy.org/tools/pi tool.html).
b Sequence similarity was  searched on June, 2011 using the NC-1 sequence (SKSSITITNKRLTRK) as a starting query sequence.
Table 2
Induction of protection against Taenia crassiceps infection by NC-1/BSA immunisation.
Immunogen Individual number of cysts Parasites recovered
(mean  ± SD)a
Protection (%)
NC-1/BSA 1,  243, 0, 91, 60, 14, 0 58.4 ±  88.7 74.2
TcCa  143, 38, 0, 38, 134, 0, 0 50.4 ± 64.1 77.7
BSA 361,  327, 293, 34, 156, 341, 135, 164 226.4 ± 119.5 –
a Recovery of cysticerci was performed on day 30 after challenge. One-way analysis of variance revealed no signiﬁcant difference between the NC-1 peptide coupled to
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Fig. 3. Effect of immunisation on the number and on the size of Taenia crassiceps
metacestodes  recovered from challenge infections. Mice were immunised intra-
peritoneally with 20 g of each immunogen at 2-week intervals. Seven days after
the last immunisation, mice were challenged with 5 budding T. crassiceps cysticerci.ovine serum albumin (NC-1/BSA) and Taenia crassiceps crude antigen (TcCa) group
ith BSA (negative control group).
cCa presented similar rates of protection. Conversely, protection
n these groups was signiﬁcantly different from that of the control
roup (one-way ANOVA; p < 0.05).
.4.  Inﬂuence of immunisation on cysticerci development
Cysticerci in the mouse peritoneum were counted and classi-
ed according to length or diameter and developmental stage—i.e.
nitial or larval stage (absence or presence of buds, respec-
ively) or ﬁnal stage. The Chi-square test allowed us to verify
hat the stage of development of cysticerci recovered from mice
mmunised with NC-1/BSA was signiﬁcantly different (p < 0.0001,
hi-square = 58) from that of the cysticerci from the negative con-
rol group (Table 3). The absence of immune protection allowed
 high number of cysticerci to develop and persist, especially
t the larval stage, a phase considered to be reproductive. As
xpected, in relation to developmental stage, the level of protec-
ion in the TcCa group was  different from that in the BSA group
p < 0.0001, Chi-square = 16). These results indicate a signiﬁcant
ssociation between each immunogen and the stage of parasite
evelopment.
The inﬂuence of immunisation on the cysticerci development
as veriﬁed when the length or diameter of cysts was  measured
fter classiﬁcation (Fig. 3). Because of the high variation between
arasite dimensions, they were separated into 3 groups: ≤1 mm,
< x < 5 mm,  and ≥5 mm.  The coupled peptide and the crude anti-
en induced resistance in mice and similarly prevented an increase
n the size of the parasites when compared with control group.
n the other hand, although NC-1/BSA immunised mice had a
maller number of larval cysticerci, animals exhibited a more pro-
ounced number of ≤1 mm cysticerci than TcCa group (p < 0.005,
tudent’s test) meaning active reproduction. These results indi-
ate that NC-1/BSA was not as efﬁcient as TcCa in inhibiting
udding.ever, both groups were statistically different (p < 0.05) from the group immunised
3.5. Localisation of NC-1 immunoreactive proteins on T.
crassiceps metacestode
Mice  serum containing antibodies produced against the
synthetic mimotope NC-1/BSA, TcCa, and BSA were used to
immunolocalise native protein(s) in metacestodes of T. crassiceps.
We performed an indirect immunoﬂuorescence on the larval and
ﬁnal stages of the parasite. Immunoﬂuorescence staining of mouseParasite  burden was  measured 30 days after challenge, and the cysts were quantiﬁed
and classiﬁed by size. The results are mean of cysticerci number ± SD of 7–8 mice.
Statistically  signiﬁcant differences (Student’s test) related to the number of ≤1 mm
cysticerci from NC-1/BSA- and TcCa-immunised mice are indicated by an asterisk
(p  < 0.005).
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Table 3
Morphometric analysis of metacestodes recovered from the peritoneum of immunised mice and the inﬂuence of immunisation on the development stage of the cysticerci.a
Immunogen Mice
examined (n)
Total length (mm)
(mean  ± SD)
Cysticerci stage (n)
Initial Larval Final
NC-1/BSA 7 1.83 ± 1.09 240 169 0
NC-1/BSA  ×BSA Chi-square = 58; p < 0.0001
TcCa 7 2.02  ± 1.15 175 178 0
TcCa  ×BSA Chi-square = 16; p < 0.0001
BSA 8 2.49 ± 1.34 690 1120 1
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pa The inﬂuence of NC-1 peptide coupled to bovine serum albumin (NC-1/BSA) i
TcCa) immunogen had a Chi-square value of 6 and p = 0.015.
ccurred mainly on the surface of the tegument (Fig. 4I). Different
eactivity occurred in response to the internal tissues with TcCa
ntibodies; although the labelling was predominantly tegument
taining, proteins from parenchyma cells were also signiﬁcantly
eactive (Fig. 4H).
The  reactivity proﬁle changed when sections of the ﬁnal stage
f the metacestode were used. The immunoﬂuorescence displayed
fter using antibodies produced against TcCa was homogeneous
n both parenchyma and tegument (Fig. 5H). This homogeneity
as also veriﬁed when anti-NC-1/BSA antibodies were assayed,
ut curiously, an intense staining pattern of all tissue components
f the section occurred as well (Fig. 5I). As expected, no reactivity
as detected in sections incubated with mouse anti-BSA antibod-
es used as a negative control when tested on either the larval (see
ig. 3G) or the ﬁnal stage of the developing parasite (see Fig. 4G).
ig. 4. Immunoﬂuorescence staining of the larval stage of the Taenia crassiceps metace
gainst bovine serum albumin (BSA; G), Taenia crassiceps crude antigen (TcCa; H), or NC-
),  an intense ﬂuorescence can be seen on the tegument, but only TcCa antibodies stained
isible  light image obtained using a differential interference contrast ﬁlter (A, B, C) and re
arenchyma (p) and tegument (t). Scale bar = 20 m.isation on cyst development compared to that of Taenia crassiceps crude antigen
4. Discussion
We  have shown that NC-1 (SKSSITITNKRLTRK) can identify
human neurocysticercosis on ELISA because it was selected using
phage display by antibodies produced against T. solium antigens.
NC-1 has induced antibodies that recognised four ∼45-kDa iso-
forms in a 2D SDS-PAGE assay and speciﬁc regions of suckers and
the tissue surrounding the cysticercus scolex in an immunohisto-
chemical assay [2].
The  approach of using a peptide screened using phage display
through speciﬁc antibodies is based on the fact that selected amino
acid sequences can be identical [19,20] or present physicochem-
ical characteristics or spatial organisation similar enough to the
original epitope [21,22] to induce an immunoprotective response.
In reference to NC-1 peptide properties [2] and to several previ-
stode. Sections of 7-m thickness were incubated with control serum antibodies
1/BSA (I) and with Alexa 488-labelled anti-mouse antibody. In both images (H and
 the parenchyma uniformly (H). Each row of images shows the same section with a
vealed with 4′ ,6-diamindino-2-phenylindole-stained nuclei (D, E, F). Arrowheads:
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Fig. 5. Immunoﬂuorescence staining of the ﬁnal stage of the Taenia crassiceps metacestode. Sections of 7-m thickness were incubated with control serum antibodies against
bovine serum albumin (BSA; G), Taenia crassiceps crude antigen (TcCa; H), or NC-1/BSA (I) and with Alexa 488-labelled anti-mouse antibody. Uniform staining was observed
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mhen TcCa antibodies were assayed (H), but it was at a much lower intensity th
ection with a visible light image obtained using a differential interference contrast
rrowheads: parenchyma (p) and tegument (t). Scale bar = 20 m.
us studies that have investigated the capacity of phage-displayed
eptides to induce immunoprotection against toxins [3,23], bacte-
ia [4], viruses [5], fungi [6], endo- [7,8] and ectoparasites [24] the
im of this investigation was to evaluate whether a T. solium NC-1
eptide would induce an immune response able to cross-protect
ice against murine cysticercosis.
Taking  into consideration the recent discussions about the use of
urine infections with T. crassiceps metacestodes in studies about
uman and porcine cysticercosis [25,26], mice were immunised
ith NC-1 coupled to BSA and challenged with T. crassiceps cys-
icerci after all animals, including the controls, presented the same
erum reactivity owing to repetitive booster inoculations. Com-
ared to animals that received exclusively BSA as an immunogen,
C-1/BSA impaired parasitaemia. Numerically, this protection was
ot signiﬁcantly different from that induced in the group immu-
ised with TcCa, and both immunogens also inﬂuenced the stage
f development and size of cysticerci. The statistical data indicate
hat NC-1 was not as efﬁcient as TcCa in inhibiting budding, as
emonstrated by the higher number of cysticerci in the initial stage.
his result was not completely unexpected because NC-1 repre-
ents only 1 epitope, whereas TcCa is a miscellany of immunogenic
roteins.
Some phage-displayed peptides are called mimotopes because
hey are not homologue sequences to the antigen but can induce
ntibodies that recognise the mimotope and the original antigen
wing to conformational similarities between them. In our exper-
ments, this reactivity can be seen in immunostaining images of
he larval stage in which an anti-NC-1 antibody reaction occurred
ainly on the surface of the tegument.t when NC-1/BSA antibodies were used (I). Each row of images shows the same
(A, B, C) and revealed with 4′ ,6-diamindino-2-phenylindole-stained nuclei (D, E, F).
The  tegument of platyhelminthes, including Cestoda and Trema-
toda, consists of 2 layers: an outer anucleated syncytium and
an inner nucleated region composed of a muscular layer. The
surface syncytium of T. crassiceps is rich in large mitochondria
[27] and enzymes for mitochondrial energy metabolism, including
cytochrome c oxidase and NADH dehydrogenase [28,29]. Although
some further analysis is required to identify the protein that can
be effectively mimicked by the NC-1 peptide, the alignment with
proteins from Taenia sp deposited in the GenBank database showed
some identity between NC-1 and sequences of cytochrome c oxi-
dase subunit III, and subunit IV of NADH dehydrogenase.
Mutations in complex I have made Caenorhabditis elegans sus-
ceptible to oxidative stress and seem to interfere with the functions
of other mitochondrial respiratory chain complexes [30]. These
data indicate these proteins may  be relevant for the survival of
tapeworms because they maintain the redox balance and con-
trol the production of oxygen free radicals in cells. Therefore,
the strong immunoreactivity shown by anti-NC-1 antibodies on
the ﬁnal stage of T. crassiceps is indicative of a possible defence
strategy. Further experiments may  help us understand how com-
plexes from the inner mitochondrial membrane that are involved
in metabolic functions could induce immunoprotection. A hypoth-
esis to be tested is whether T. crassiceps metacestode can secrete
these proteins. Studies of the excretory/secretory proteomes of
larval forms from 2 platyhelminthes, Schistosoma mansoni and Echi-
nostoma caproni, have described several enzymes, including NADH
dehydrogenase found in the extracellular environment [31].
NC-1  locating at the cysticercus tegument or in excre-
tory/secretory products favours its recognition by patient serum
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2], suggesting that the presence of the peptide could be tested
n the diagnosis of swine and bovine cysticercosis provoked by T.
olium and T. saginata metacestodes, respectively. Furthermore, the
mmunoreactivity of sera from NC-1/BSA-immunised mice indi-
ates that mimotope-induced antibodies may  target an important
andidate antigen for a vaccine. Humoral response has shown to
e crucial in some cases of cestode infection—for example, in T.
ydatigena infection, antibodies from an infected host protected
nimals that received passively transferred immune serum [32].
tudies have suggested that the high protective capacity of immune
erum against the recombinant protein TSOL18, a speciﬁc protein
rom T. solium, is related to antibodies and complement-mediated
ctivities [33].
Most  of the peptides selected by phage display are confor-
ational epitopes, and data from our previous studies [2] have
ndicated that NC-1 is a peptide for which antibody binding
s dependent on conformation. Curiously, recombinant proteins
SOL18 as well as EG95, a protective hydatid vaccine antigen
34], are able to induce antibodies that recognise conformational
pitopes. Further studies must be done, but the efﬁciency of host-
rotective antibodies against cestode parasites may  be inﬂuenced
y conformational rather than linear antigenic determinants.
The  protection induced by NC-1 was better than 70%. Improved
mmune response to small peptides could be realised by using a
ombination of synthetic epitopes [35], and different adjuvants [36]
r by using liposomes [37] as carriers and adjuvants. Our obser-
ations about the immunogenicity of NC-1 have proven that this
eptide is a potential immunotarget for vaccine development and
hat a protective immunological response against parasites can
e induced by a synthetic peptide immunoselected facing speciﬁc
ntibodies.
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